menu
The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, - Roots Analysis
The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, - Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

Roots Analysis is pleased toannounce the publication of its recent study, titled, “DrugRepurposing Service Providers Market, 2020-2030.

 

Thereport features an extensive study of the current market landscape and futureopportunities for players offering services for repurposing / repositioning /reprofiling of drug candidates. It features an in-depth analysis, highlightingthe capabilities of various service providers engaged in this domain. Inaddition to other elements, the study includes:

§  Adetailed assessment of the current market landscape of companies offering drugrepurposing services. 

§  Elaborateprofiles of key players that specialize in offering services for thedevelopment of repurposed drugs.

§  Ananalysis of the partnerships that have been established in this domain, in therecent past.

§  Ananalysis of the initiatives of big biopharma players engaged in this domain.

§  A detailedanalysis of more than 1,700 terminated / withdrawn / suspended clinical studiesof the drug candidates.

§  A detailedanalysis on the cost saving potential of drug repurposing approaches, ascompared to the traditional de novo drug development methods.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

  • Type of Repurposing Approaches

§  Disease-centricapproach

§  Target-centricapproach

§  Drug-centricapproach

  • Therapeutic Area

§  SameTherapeutic Area

§  DifferentTherapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  SmallMolecule

  • Key Geographical Region 

§  NorthAmerica

§  Europe

§  Asia-Pacific

 

Keycompanies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

Formore information please click on the following https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.    Peptidesand Macrocycle Drug Discovery: Services and PlatformsMarket, 2020 - 2030

2.    ChinaBiopharmaceutical Contract Manufacturing Market, 2020-2030

3.    AntibodyContract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

RootsAnalysis is one of the fastest growing market research companies, sharing freshand independent perspectives in the bio-pharmaceutical industry. The in-depthresearch, analysis and insights are driven by an experienced leadership teamwhich has gained many years of significant experience in this sector. If you’dlike help with your growing business needs, get in touch atinfo@rootsanalysis.com

 

Contact Information

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

gaurav.chaudhary@rootsanalysis.com